BRAF, MEK inhibitors ‘saving lives’ as histiocytic disorder treatment
Key takeaways: NEW ORLEANS — BRAF and MEK inhibitors may show promise as a treatment option for children and adults with histiocytic disorders, according to a presenter here. Langerhans cell histiocytosis (LCH), categorized under histiocytic neoplasms, is a rare pediatric disease affected one in every 200,000 children, Ashish Kumar, MD, PhD, of Cincinnati Children’s Hospital …
BRAF, MEK inhibitors ‘saving lives’ as histiocytic disorder treatment Read More »